Stock listing

OTC:MOTS Motus GI Holdings, Inc. Stock

Follow Motus GI Holdings, Inc. into a list and get an email when it puts out news.

Share price · OTC:MOTS

$0.0002 USD 0.0000 (0.0%)

Close on Nov 11, 2026

Past year 0.0% · daily closes, Nov 11, 2025 – Nov 11, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 11, 2026
Volume
834 sharesNov 11, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.0001 – $0.1000 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
Traded on an average day
$0 USDMedian day 0 shares · 44 days with no trades · last 3 months, Aug 11, 2026 – Nov 11, 2026
Motus GI Holdings, Inc. logo

Daily closes

Last 3 months, Aug 11, 2026 – Nov 11, 2026 · OTC:MOTS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.0002834
$0.00020.00000.0%$0.0002$0.0002$0.0002133
$0.00020.00000.0%$0.0002$0.0002$0.00022,568
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00021,005
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00025,102
$0.00020.00000.0%$0.0002$0.0002$0.00022,506
$0.00020.00000.0%$0.0002$0.0002$0.0002124
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002266
$0.00020.00000.0%$0.0002$0.0002$0.0002470
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002250
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002922
$0.00020.00000.0%$0.0002$0.0002$0.00021,003
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00022,752
$0.00020.00000.0%$0.0002$0.0002$0.000111,087
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00021,434
$0.00010.00000.0%$0.0001$0.0001$0.0001501
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00011,502
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010

Splits

2 splits since 2022 · OTC:MOTS · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
1-for-20Consolidation
Ticker
OTC:MOTS
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

Motus GI Holdings, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
Calls
9 calls with a replay · 9 with a transcript · latest Nov 14, 2022
Decks
9 decks · latest Dec 5, 2023

Valuation

price Nov 11, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.00

Events

Results days

QuarterResultsShare move
Q1 2024May 14, 2024 · After close+7.9%
Q4 2023Mar 18, 2024 · After close−16.6%
Q3 2023Nov 13, 2023 · After close+10.8%
Q2 2023Aug 14, 2023 · After close−4.3%
Q1 2023May 10, 2023 · After close−0.4%
Q4 2022Mar 31, 2023 · After close−4.5%
Q3 2022Nov 14, 2022 · After close−9.1%
Q2 2022Aug 11, 2022 · After close−4.4%
Q1 2022May 12, 2022 · After close+3.8%
Q4 2021Mar 29, 2022 · After close−4.6%
All 14 quarters
QuarterResultsShare move
Q3 2021Nov 12, 2021 · Before open+3.3%
Q2 2021Aug 12, 2021 · After close−11.1%
Q1 2021May 13, 2021 · After close+3.8%
Q4 2020Mar 16, 2021 · After close+4.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2023)Investor deck22 slidesDec 5, 2023
Investor Presentation (June 2023)Investor deck19 slidesJun 8, 2023
Investor Presentation (April 2023)Investor deck19 slidesApril 2023
Investor Presentation (October 2022)Investor deck19 slidesOctober 2022
Investor Presentation (March 2022)Investor deck21 slidesMarch 2022
Investor Presentation (November 2018)Investor deck25 slidesNov 15, 2018
Investor Presentation (August 2018)Investor deck25 slidesAug 14, 2018
Investor Presentation (June 2018)Investor deck24 slidesJun 4, 2018
Investor Presentation (March 2018)Investor deck26 slidesMar 20, 2018

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue319.0K592.0K391.0K98.0K107.0K36.0K7.00K00
Cost of revenue907.5K796.0K624.0K496.0K136.0K54.0K3.00K46.0K45.0K
Gross profit-588.5K-204.0K-233.0K-398.0K-29.0K-18.0K4.00K-46.0K-45.0K
Research and development3.47M5.61M5.34M5.55M9.01M6.05M4.27M3.08M3.16M
Selling, general and administrative6.58M7.61M9.27M9.56M9.50M8.55M6.29M1.86M1.74M
Operating income-11.9M-17.9M-17.9M-19.0M-23.4M-18.9M-13.0M-6.01M-5.33M
Depreciation and amortization677.0K837.0K701.0K377.0K223.0K152.0K65.0K46.0K45.0K
EBITDA-11.2M-17.0M-17.2M-18.7M-23.2M-18.8M-12.9M-5.96M-5.28M
Interest expense761.0K1.25M717.0K464.0K006.00K86.0K5.00K
Income before tax-12.9M-18.6M-19.0M-19.3M-23.1M-22.3M-13.2M-7.97M-5.96M
Income tax-506.0K-122.0K342.0K-492.0K-3.33M-246.0K50.0K29.0K
Net income-12.9M-18.1M-18.9M-19.6M-22.6M-22.3M-13.2M-8.02M-5.99M
Earnings per share, basic-15.89-83.81-120.98-183.06-269.69-441.11-383.25-154.54-115.40

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents4.96M14.0M22.6M20.8M20.5M18.1M6.94M11.6M1.29M
Short-term investments08.20M3.04M76.0K7.00K
Receivables76.0K59.0K109.0K35.0K83.0K5.00K602.0K229.0K53.0K
Inventory245.0K488.0K496.0K805.0K1.01M23.0K6.00K81.0K-53.0K
Current assets5.76M15.4M24.0M22.1M30.2M22.1M8.29M12.0M1.47M
Property, plant and equipment2.12M1.94M2.08M846.0K783.0K141.0K157.0K
Total assets7.22M17.6M26.1M24.1M32.3M23.0M9.17M12.2M1.72M
Accounts payable1.84M1.97M2.58M2.33M3.00M2.14M882.0K107.0K462.0K
Current liabilities3.27M4.80M2.90M10.6M11.3M2.39M1.98M752.0K698.0K
Long-term debt1.24M8.48M11.4M4.74M
Total debt2.47M11.4M12.1M8.76M8.79M4.74M
Total liabilities4.54M14.7M16.4M12.8M13.9M4.44M3.65M2.16M5.44M
Shareholders' equity2.69M2.98M9.66M11.3M18.3M18.5M5.52M10.0M-3.72M
Shares outstanding809.5K215.9K156.3K107.1K83.8K50.5K34.4K51.9K51.9K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-11.4M-17.5M-14.4M-17.0M-19.9M-14.9M-10.4M-6.13M-4.92M
Capital spending-104.0K-224.0K-470.0K-88.0K-468.0K-547.0K-707.0K-30.0K-68.0K
Free cash flow-11.5M-17.7M-14.9M-17.1M-20.4M-15.5M-11.1M-6.16M-4.99M
Cash from investing-470.0K8.12M-5.62M-3.50M-751.0K-6.00K-154.0K
Cash from financing2.41M9.17M16.6M9.17M28.0M29.5M6.44M16.5M5.62M
Dividends paid-1.48M
Share buybacks-12.0K-11.0K058.0K20.0M31.0M6.47M7.32M1.51M
Change in cash-9.08M-8.52M1.74M291.0K2.48M11.1M-4.71M10.4M544.0K

Open Financials

Cap table

Built by 6ix from Motus GI Holdings, Inc.’s releases

Common shares
6,388,876
Fully diluted
6,388,876

Fully diluted

LineShares
Common shares6,388,876

Share count over time

CountShares
Nov 22, 20266,388,876

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David P. Hochman
Other companies: Orchestra BioMed Holdings, Inc. (See Remarks, Director · Since at least Jan 26, 2023); Corbus Pharmaceuticals Holdings, Inc. (Director · Nov 10, 2017 – May 20, 2020 · Past)
Director · Feb 13, 2018 – Feb 13, 2019 · Past
Gary J. Pruden
Other companies: Lantheus Holdings, Inc. (Director · Since at least Feb 26, 2018); Johnson & Johnson (Exec VP, WW Chair, Med Devices · Apr 28, 2016 – Feb 28, 2017 · Past)
Director · Feb 13, 2018 – Mar 5, 2024 · Past
Samuel R Md Nussbaum
Other companies: Coherus Oncology, Inc. (Director · May 9, 2018 – Jan 11, 2021 · Past); Elevance Health, Inc. (EVP & Chief Medical Officer · Apr 4, 2007 – May 19, 2015 · Past)
Director · Feb 13, 2018 – Feb 17, 2021 · Past
Scott Durbin
Other companies: Viveve Medical, Inc. (Chief Executive Officer, Director · Jun 17, 2016 – Jan 3, 2023 · Past); Vericel Corporation (CFO · Jan 4, 2012 – Jan 4, 2012 · Past)
Director · Sep 6, 2023 – Mar 5, 2024 · Past
Sonja Nelson
Other companies: Ambrx Biopharma Inc. (Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past); ImmunityBio, Inc. (Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past)
Director · Jun 22, 2021 – Mar 5, 2024 · Past
Timothy Moran
Other companies: Kestra Medical Technologies, Ltd. (Chief Business Officer · Since at least Oct 7, 2025); Adagio Medical Holdings, Inc (Director · Since at least Jul 31, 2024)
Director · Nov 11, 2020 – Mar 5, 2024 · Past
Andrew Taylor
Other companies: Orchestra BioMed Holdings, Inc. (Chief Financial Officer · Since at least Jun 6, 2023)
Chief Financial Officer · Feb 13, 2018 – Feb 10, 2022 · Past
Darren R. Sherman
Other companies: Orchestra BioMed Holdings, Inc. (See Remarks, Director · Since at least Jan 26, 2023)
Director · Oct 12, 2020 – Feb 10, 2022 · Past
Elad AmorChief Accounting Officer · Jun 2, 2023 – Jun 2, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Motus GI Holdings, Inc.